The 7th Annual Dry AMD and Geographic Atrophy Therapeutics Summit highlights advancements in therapeutic strategies, delivery systems, and regulatory pathways for treating Dry AMD and Geographic Atrophy.
Key Topics
Mechanisms and innovations in early intervention to preserve vision in Dry AMD
Global development strategies for regulatory approvals in retinal therapies
Novel therapeutic targets beyond the complement pathways
AI, imaging, and predictive analytics in Dry AMD and GA research
Targeted and sustained ocular drug delivery systems
Clinical trial readouts and precision approaches in Dry AMD and GA
Clinically meaningful endpoints for regulatory and clinical adoption
